⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5072514 | 0.94 | ALDH1A1 (0.32) | — | |
| SCHEMBL38296 | 0.94 | ALDH1A1 (0.32) | — | |
| SCHEMBL2238894 | 0.94 | ALDH1A1 (0.32) | — | |
| SCHEMBL5070157 | 0.94 | ALDH1A1 (0.32) | — | |
| SCHEMBL458413 | 0.94 | ALDH1A1 (0.32) | — | |
| SCHEMBL6747192 | 0.94 | — | — | |
| Bromide SCHEMBL11466560 | 0.94 | — | — | |
| SCHEMBL28544 | 0.94 | — | — | |
| SCHEMBL22116424 | 0.94 | ALDH1A1 (0.32) | — | |
| SCHEMBL5072438 | 0.94 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119654316-A | Thioglutarimide isoindolinone skeleton-based compound and application thereof | 标新生物医药科技(上海)有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119451952-A | Oxo-isoindolinyl substituted tetrahydropyrimidinedione derivative and application thereof | 标新生物医药科技(上海)有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118556047-A | Oxo-isoindolinyl substituted piperidinedione derivative and application thereof | 标新生物医药科技(上海)有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118556048-A | Sulfur/oxygen substituted glutarimide isoindolinone skeleton-based compound and application thereof | 标新生物医药科技(上海)有限公司 | 2024-08-27 | — | — | CN | claimed |
| WO-2024140637-A1 | OXOISOINDOLINYL SUBSTITUTED PIPERIDINEDIONE DERIVATIVE AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-07-04 | — | — | WO | claimed |
| CN-117881668-A | Compound based on isoindoline substituted glutarimide skeleton and application thereof | 标新生物医药科技(上海)有限公司 | 2024-04-12 | — | — | CN | claimed |
| US-20240092815-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-03-21 | — | — | US | claimed |
| WO-2024044486-A1 | JAK2 INHIBITOR COMPOUNDS | AJAX THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | claimed |
| WO-2024032689-A1 | COMPOUND BASED ON ISOINDOLINE-SUBSTITUTED GLUTARIMIDE BACKBONE AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-02-15 | — | — | WO | claimed |
| WO-2023159322-A1 | QUINAZOLINE DERIVATIVES AS INHIBITORS OF THE GCN2 KINASE, COMPOSITIONS AND USES THEREOF | ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) | 2023-08-31 | — | — | WO | claimed |
| EP-1480635-A4 | MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS LLC (US) | 2005-06-29 | — | — | EP | claimed |
| WO-2005030711-A2 | BRIDGED MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS LLC (US) | 2005-04-07 | — | — | WO | claimed |
| EP-1480635-A2 | MACROCYCLIC MODULE COMPOSITIONS | Covalent Partners, LLC (US) | 2004-12-01 | — | — | EP | claimed |
| US-20030199688-A1 | Macrocyclic module compositions | COVALENT PARTNERS, LLC | 2003-10-23 | — | — | US | claimed |
| WO-2003066646-A2 | MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS, LLC (US) | 2003-08-14 | — | — | WO | claimed |
| US-6248920-B1 | REACTING AN ALDEHYDE OR KETONE COMPOUND AND AN ACID HALIDE COMPOUND IN A ONE POT REACTION IN THE PRESENCE OF AN ORGANOMETALLIC COMPOUND TO DIRECTLY FORM THE ESTERS WITHOUT FORMING AN INTERMEDIATE ALCOHOL | FUJITSU LIMITED (JP) | 2001-06-19 | — | — | US | claimed |
| US-6207342-B1 | PHOTORESIST OF ACID SENSITIVE TERPOLYMER AND PHOTOACID GENERATOR | FUJITSU LIMITED (JP) | 2001-03-27 | — | — | US | claimed |
| US-5879851-A | Method for forming resist patterns by using an ammonium or morpholine compound as a developer | FUJITSU LIMITED (JP) | 1999-03-09 | — | — | US | claimed |
| WO-1993002204-A1 | PRODUCTION OF GINKGOLIDES IN CELL CULTURE | HAN-DOK REMEDIA IND. CO., LTD. (KR) | 1993-02-04 | — | — | WO | claimed |
| EP-0502706-A1 | 1-Oxa-2,9-diphenyl-spiro[4.4]nonane derivatives as PAF antagonists | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1992-09-09 | — | — | EP | claimed |